Special Issue "The Value(s) of Vaccination: Health Assessment"
Deadline for manuscript submissions: 31 October 2023 | Viewed by 6948
Interests: attitudes and beliefs on influenza vaccination; Health Technology Assessment (HTA); value-based healthcare; pharmaeconomic evaluations; public-health policies; epidemiology and prevention of infectious diseases; health promotion and health literacy
Interests: public health; epidemiology; e-health; mental health; minority health
Special Issues, Collections and Topics in MDPI journals
The benefits of vaccines are recognized globally. However, many challenges still need to be addressed to increase vaccination coverage and to ensure universal immunization.
Vaccinations are fundamental to the control of infectious diseases. In addition to reducing mortality and morbidity rates and limiting the spread of pathogens, vaccination plays an important role in the fight against antimicrobial resistance, and this represents an important value that is not yet fully captured. Vaccine-preventable diseases (VPDs) have very important impacts not only on health systems but also on social care and productive and economic systems. Vaccination contributes to health systems’ sustainability through savings generated in terms of the reduction of hospitalizations, direct medical costs, and any short- and long-term complications related to potential outbreaks. It also reduces the lack of productivity due to absence from work and contributes to maintaining a healthy population.
Not recognizing and analyzing all the benefits of vaccines and vaccination, in terms of benefits at family, community and national level, these could be underestimated. The economic impact of vaccinations should incorporate health and non-health benefits of vaccination in both vaccinated and unvaccinated populations, thus allowing for the estimation of the net social value of vaccination. The full benefits of vaccination reach beyond the direct prevention of etiologically confirmed disease, and often extend across the life course of a vaccinated person, prevent outcomes in the wider community, stabilize health systems, promote health equity, and benefit local and national economies. Therefore, future economic evaluations should pay more attention to the effect of vaccination on preventing complications, on generating health gains for caregivers, and on community benefits beyond individual protection.
Hence, evidence-based tools to support vaccine-related decision-making processes (e.g., value-based healthcare (VBHC), HTA, new models for economic evaluations) are certainly needed.
Furthermore, an exploitation of the broad value of vaccines and vaccination could help contrasting several concerns, such as unequal access, lack of resources, and vaccine hesitancy.
The understanding of the broad value of vaccination and the effective translation of this knowledge to different stakeholders is therefore important to strengthen vaccination policies and strategies and counteract both disinformation and misinformation.
We are pleased to invite you to submit an article to this Special Issue on The Value(s) of Vaccination: Health Assessment. Research areas may include (but are not limited to) the following: (1) allocative value of vaccination; (2) technical value of vaccines; (3) personal value of vaccination; (4) societal value of vaccination; (5) actions and strategies for value-based decision-making on vaccination; (5) evidence-based tools to support the health technology assessment of vaccines; (6) new economic evaluation frameworks to assess the value of vaccines; (7) strategies to improve vaccine access and equality; (8) assessment and interventions to promote the full value of vaccination; and (9) the value(s) of vaccination for special populations including older adults, children, pregnant women, and healthcare workers. This Special Issue will include studies on COVID-19, routine vaccinations, experimental vaccines and vaccine-preventable diseases. Original research articles and reviews are welcome.
We look forward to receiving your contributions.
Dr. Giovanna Elisa Calabrò
Prof. Dr. Fabrizio Bert
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccine-preventable diseases
- values of vaccination
- value-based healthcare
- economic evaluation
- interventions and strategies
- vaccine hesitancy
- public health